The effect of rosuvastatin on inflammation, matrix turnover and left ventricular remodeling in dilated cardiomyopathy: a randomized, controlled trial (Q31152172)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The effect of rosuvastatin on inflammation, matrix turnover and left ventricular remodeling in dilated cardiomyopathy: a randomized, controlled trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

The effect of rosuvastatin on inflammation, matrix turnover and left ventricular remodeling in dilated cardiomyopathy: a randomized, controlled trial (English)

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

0 references

dilated cardiomyopathy

1 reference

based on heuristic

inferred from title

ventricular remodeling

1 reference

based on heuristic

inferred from title

12

object named as

Pål Aukrust

0 references

4

object named as

Thor Ueland

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

13

object named as

Lars Gullestad

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

5

object named as

Arne Yndestad

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

6

object named as

Kristin Godang

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

1

object named as

Kaspar Broch

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Erik T Askevold

2

object named as

Erik T Askevold

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Wenche Stueflotten

7

object named as

Wenche Stueflotten

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Hans-Jørgen Smith

10

object named as

Hans-Jørgen Smith

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

11

object named as

Svend Aakhus

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

author name string

Erik Gjertsen

3

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Johanna Andreassen

8

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Rolf Svendsmark

9

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

language of work or name

0 references

publication date

25 February 2014

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

9

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

e89732

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

copyright license

Creative Commons Attribution 4.0 International

25 February 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Soluble glycoprotein 130 predicts fatal outcomes in chronic heart failure: analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3934914

21 June 2018

Inflammatory cytokines in heart failure: mediators and markers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3934914

21 June 2018

Mechanisms for the anti-inflammatory effects of statins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3934914

21 June 2018

Plasma Biomarkers That Reflect Determinants of Matrix Composition Identify the Presence of Left Ventricular Hypertrophy and Diastolic Heart Failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3934914

21 June 2018

Osteoprotegerin predicts progression of chronic heart failure: results from CORONA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3934914

21 June 2018

The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in cardiovascular disease: a comprehensive review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3934914

21 June 2018

Why did high-dose rosuvastatin not improve cardiac remodeling in chronic heart failure? Mechanistic insights from the UNIVERSE study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3934914

21 June 2018

Meta-analysis of randomized controlled trials of statins versus placebo in patients with heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3934914

21 June 2018

Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3934914

21 June 2018

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3934914

21 June 2018

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3934914

21 June 2018

Rosuvastatin in older patients with systolic heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3934914

21 June 2018

Systemic inflammation in heart failure--the whys and wherefores

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3934914

21 June 2018

Circulating markers of endothelial function in cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3934914

21 June 2018

Recommendations for chamber quantification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3934914

21 June 2018

Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3934914

21 June 2018

HMG-CoA reductase inhibitors for lowering elevated levels of C-reactive protein.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3934914

21 June 2018

Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3934914

21 June 2018

The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3934914

21 June 2018

Inflammatory predictors of mortality in the Scandinavian Simvastatin Survival Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3934914

21 June 2018

Matrix metalloproteinase disruption of the extracellular matrix and cardiac dysfunction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3934914

21 June 2018

Statistics notes: Analysing controlled trials with baseline and follow up measurements

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3934914

21 June 2018

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3934914

21 June 2018

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0089732

21 January 2018

Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure.

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0089732

21 January 2018

Usefulness of atorvastatin in patients with heart failure due to inflammatory dilated cardiomyopathy and elevated cholesterol levels

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0089732

21 January 2018

Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0089732

21 January 2018

CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials.

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0089732

21 January 2018

Recommendations of the European Association of Echocardiography: how to use echo-Doppler in clinical trials: different modalities for different purposes

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0089732

21 January 2018

Visual assessment of valvular regurgitation: comparison with quantitative Doppler measurements.

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0089732

21 January 2018

Positive effects of a physiological dose of GH on markers of atherogenesis: a placebo-controlled study in patients with adult-onset GH deficiency

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0089732

21 January 2018

Independent and additional prognostic value of aminoterminal propeptide of type III procollagen circulating levels in patients with chronic heart failure.

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0089732

21 January 2018

Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0089732

21 January 2018

Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0089732

21 January 2018

Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0089732

21 January 2018

Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure

1 reference

https://api.crossref.org/works/10.1371/JOURNAL.PONE.0089732

21 January 2018

The influence of atorvastatin on parameters of inflammation and function of the left ventricle in patients with dilated cardiomyopathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3934914

31 October 2018

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3934914

31 October 2018

Identifiers

10.1371/JOURNAL.PONE.0089732

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

2014PLoSO...989732B

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31152172&oldid=1862502489"